🔗 Share this article

A shadow economy for unapproved slimming drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, based on new investigations.

Experimental Treatment Acquiring Traction Via Social Media

The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its alleged fat-burning effects. Followers are urged to message these profiles privately for source information, while also receiving promotional offers.

Active Trade on Messaging Platforms

Additionally, a flourishing trade exists on Telegram, where communities with thousands of members share comparison photos, administration instructions and assertions of next-day British shipping. Vendors promote the substance there before directing buyers to WhatsApp for purchases.

Learning About Retatrutide

Retatrutide is an experimental injection developed by US drugmaker Eli Lilly. The treatment targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could assist patients reduce up to a quarter of their total weight. Referred to as the “triple G”, the substance is being promoted online as the successor to Ozempic.

Medical Experts Express Concerns

However, physicians and pharmacists have warned that the distribution of what is still an unlicensed drug in the United Kingdom is a cause for concern and could result in individuals administering products of unknown origin.

Some experts stated the demand for retatrutide could be connected to the increasing price of approved slimming products such as Mounjaro.

Regulatory Status and Implementation

Marketing retatrutide on TikTok or messaging apps is illegal in the UK, as it is an unapproved drug that must not be marketed or supplied for human use under the British medical regulations.

Several content creators attempt to sidestep the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but promotion and distribution can still breach pharmaceutical, advertising, and customer regulations, risking penalties, prosecution or prison.

Service Reaction and Material Elimination

According to the social media company, the platform has removed problematic material and banned related keywords and query recommendations. The organization said it was dedicated to maintaining the service secure and investing in enhancing compliance measures.

Digital Marketplace Activities

Research also discovered groups with up to nine thousand members selling retatrutide using Telegram's integrated discovery tool, which functions like a online catalog. Entering “retatrutide” instantly displays channels with thousands of users, populated with images of slimming results, positive reviews and step-by-step guides for preparing or injecting at residence.

After moments of joining one community, a seller posted WhatsApp details, where most transactions take place. The vendor provided an instruction manual and guaranteed shipping within 48 hours. When questioned whether the substance was genuine, one seller said: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. Not one inquired about body mass, health issues or past usage.

Product Information and Pricing

Inside these groups, messages display dark colored packages with postal service labels, stating to contain new batches. One message stated: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, mixed at home with purified liquid, or ready-to-use injectors typically priced at £160 for 20 milligrams. When questioned how long a injector should be used, vendors give conflicting answers varying between a several days to “depends on your body”.

Platform Oversight and Safety Actions

A spokesperson for the messaging service stated it actively moderated dangerous material on its service including material that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Warnings

“People are injecting materials they cannot confirm. Even if the research behind this drug is sound, these online versions may not include what they claim,” said Jason Murphy, the head of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor connected the surge in interest to recent cost increases for approved weight-loss medications such as Mounjaro. “With costs increasing, individuals are using online platforms. But counterfeit injections are extremely dangerous. You can’t be certain what’s inside or whether the conditions they were produced in was sterile,” she said.

Her team has previously seen individuals injured by personal administration from unverified suppliers. “We understand the disappointment, but buying from messaging apps or WhatsApp is taking chances with your health,” stated Wyllie. “These materials could be contaminated or improperly measured.”

Producer Statement

A spokesperson from Eli Lilly stated the substance was in third stage clinical trials and had not been evaluated or approved by any government authority globally. “Consequently at this point no one can sell [it] for personal consumption,” they said, adding that any product “misleadingly claiming itself as a company investigational substance not yet authorized … may expose users to possibly significant medical dangers”.